Home > Search Results: Bergh, Jonas
  Search Tips
Advanced Search
Search collections:
Sort by: Display results: Output format:
UAB Digital Repository of Documents 2 records found  Search took 0.02 seconds. 
1.
5 p, 324.7 KB The European Cancer Patient's Bill of Rights, update and implementation 2016 / Højgaard, Liselotte (Kobenhavns Universitet) ; Löwenberg, Bob (Erasmus University Medical Center) ; Selby, Peter (University of Leeds) ; Lawler, Mark (European Cancer Concord) ; Banks, Ian (University of Leeds) ; Law, Kate (European Cancer Concord) ; Albreht, Tit (Institut za varovanje zdravja Republike Slovenija) ; Armand, Jean-Pierre (Gustave Roussy) ; Barbacid, Mariano (Centro Nacional de Investigaciones Oncológicas) ; Barzach, Michèle (IHU Strasbourg Board of Trustees) ; Bergh, Jonas (Karolinska Institutet (Estocolm, Suècia)) ; Cameron, David (University of Edinburgh) ; Conte, Pierfranco (Istituto Oncologico Veneto) ; de Braud, Filippo (National Cancer Institute) ; de Gramont, Aimery (Institut Hospitalier Franco-Britannique) ; De Lorenzo, Francesco (European Cancer Patient Coalition) ; Diehl, Volker (Universität zu Köln) ; Diler, Sarper (Myeloma Patients Europe) ; Erdem, Sema (Europa Donna) ; Geissler, Jan (European Patients Academy on Therapeutic Innovation) ; Gore-Booth, Jola (EuropaColon) ; Henning, Geoffrey (EuropaColon) ; Horgan, Denis (European Alliance for Personalised Medicine) ; Jassem, Jacek (Medical University of Gdansk) ; Johnson, Peter (Cancer Research UK) ; Kaasa, Stein (Norges Teknisk-Naturvitenskapelige Universitet) ; Kapitein, Peter (Inspire2Live) ; Karjalainen, Sakari (Association of European Cancer Leagues) ; Kelly, Joan (Irish Cancer Society) ; Kienesberger, Anita (Austrian Childhood Cancer Organisation) ; La Vecchia, Carlo (Universita degli Studi di Milano) ; Lacombe, Denis (European Organisation for Research and Treatment of Cancer) ; Lindahl, Tomas (Francis Crick Institute) ; Luzzatto, Lucio (Universita degli Studi di Firenze) ; Malby, Rebecca (London South Bank University) ; Mastris, Ken (Europa Uomo) ; Meunier, Françoise (European Organisation for Research and Treatment of Cancer) ; Murphy, Martin (Society for Translational Oncology) ; Naredi, Peter (European Cancer Organisation) ; Nurse, Paul (Francis Crick Institute) ; Oliver, Kathy (International Brain Tumour Alliance) ; Pearce, Jonathan (Lymphoma Association) ; Pelouchov, Jana (European Cancer Patient Coalition) ; Piccart, Martine (Institut Jules Bordet) ; Pinedo, Bob (VuMC Cancer Center) ; Spurrier-Bernard, Gilly (Melanoma Patient Network Europe) ; Sullivan, Richard (Kings Health Partners Integrated Cancer Centre) ; Tabernero, Josep (Vall d'Hebron Institut d'Oncologia) ; Van de Velde, Cornelis (Leids Universitair Medisch Centrum) ; van Herk, Bert (Spaarne Gasthuis) ; Vedsted, Peter (Aarhus Universitet) ; Waldmann, Anita (Leukaemiehilfe RHEIN-MAIN) ; Weller, David (University of Edinburgh) ; Wilking, Nils (Skåne University Hospital (Suècia)) ; Wilson, Roger (Sarcoma Patients EuroNet EV) ; Yared, Wendy (Association of European Cancer Leagues) ; Zielinski, Christoph C (European Society for Medical Oncology) ; zur Hausen, Harald (University of Heidelberg) ; Le Chevalier, Thierry (Institute Gustave Roussy) ; Johnston, Patrick (European Cancer Concord) ; Universitat Autònoma de Barcelona
In this implementation phase of the European Cancer Patient's Bill of Rights (BoR), we confirm the following three patient-centred principles that underpin this initiative: The key aspects of working towards implementing the BoR are:.
2017 - 10.1136/esmoopen-2016-000127
ESMO open, Vol. 1 (january 2017)  
Detailed record - Creative Commons
2.
8 p, 257.6 KB Concordance among gene expression-based predictors for ER-positive breast cancer treated with adjuvant tamoxifen / Prat, A. (Universitat Autònoma de Barcelona. Departament de Medicina) ; Parker, J. S. (University of North Carolina. Lineberger Comprehensive Cancer Center) ; Fan, C. (LUniversity of North Carolina. Lineberger Comprehensive Cancer Center) ; Cheang, M. C. U. (University of North Carolina. Lineberger Comprehensive Cancer Center) ; Miller, L. D. (Wake Forest School of Medicine. Department of Cancer Biology) ; Bergh, Jonas (Manchester University. Department of Medical Oncology) ; Chia, S. K. L. (British Columbia Cancer Agency) ; Bernard, P. S. (University of Utah Health Sciences Center. Department of Pathology) ; Nielsen, T. O. (University of British Columbia. Department of Pathology) ; Ellis, M. J. (Siteman Cancer Center at Washington University. Department of Medicine) ; Carey, L. A. (University of North Carolina. Deparment of Medicine) ; Perou, Charles M. (University of North Carolina. Pathology & Laboratory Medicine)
ER-positive (ER+) breast cancer includes all of the intrinsic molecular subtypes, although the luminal A and B subtypes predominate. In this study, we evaluated the ability of six clinically relevant genomic signatures to predict relapse in patients with ER+ tumors treated with adjuvant tamoxifen only. [...]
2012 - 10.1093/annonc/mds080
Annals of oncology, Vol. 23 Núm. 11 (november 2012) , p. 2866-2873  
Detailed record - Creative Commons

See also: similar author names
1 Bergh, Jeroen C. J. M. van den,
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.
UAB Digital Repository of Documents :: Search :: Submit :: Personalize :: Help
Powered by Invenio v1.1.6
Maintained by ddd.bib@uab.cat  :: Metadata license:
Working with